Publications
For complete publications list, visit Dr. Merryman’s NCBI Bibliography as well as his google scholar site.
- NCBI: https://www.ncbi.nlm.nih.gov/myncbi/william.merryman.1/bibliography/public/
- Google Scholar: https://scholar.google.com/citations?user=VJW4LK4AAAAJ&hl=en
Select Publications
Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial Hypertension. Valentine MS, Bender AM, Shay S, Paffenroth KC, Gladson S, Dickerson JW, Watson KJ, Kapolka NJ, Boutaud O, Rook JM, Blackwell TS, Roth BL, Austin ED, West JD, Lindsley CW, Merryman WD. https://doi.org/10.1016/j.jacbts.2023.06.014
Myocardial Neprilysin is Increased in Hypertrophic Cardiomyopathy. Armstrong DWJ, Riley LA, Su YR, Shah AS, Absi T, Gupta DK, Wells QS, Brinkley DM, Stevenson LW, Merryman WD. https://doi.org/10.1161/circulationaha.123.064153
Impaired macrophage trafficking and increased helper T-cell recruitment with loss of cadherin-11 in atherosclerotic immune response. Johnson CL, Riley L, Bersi M, Linton MF, Merryman WD. https://doi.org/10.1152/ajpheart.00263.2021
Unloading the Stenotic Path to Identifying Medical Therapy for Calcific Aortic Valve Disease: Barriers and Opportunities. Lindman Br, Merryman WD. https://doi.org/10.1161/circulationaha.120.052531
2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery. Aaron M Bender, Lauren C Parr, William B Livingston, Craig W Lindsley, W David Merryman. https://doi.org/10.1021/acs.jmedchem.3c01178
Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction. J Caleb Snyder, Lance A Riley, Noah T Mallory, Matthew R Bersi, Prachi Umbarkar, Rekha Gautam, Qinkun Zhang, Anita Mahadevan-Jansen, Antonis K. Hatzopoulos, Luc Maroteaux, Hind Lal, W David Merryman. Circulation. 2021. https://doi.org/10.1161/CIRCULATIONAHA.120.051517
Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction. Alison K Schroer, Matthew R Bersi, Cynthia R Clark, Qinkun Zhang, Lehanna H Sanders, Antonis K Hatzopoulos, Thomas L Force, Susan M Majka, Hind Lal, W David Merryman. Journal of Clinical Investigation Insight. 2019. https://doi.org/10.1172/jci.insight.131545
Bone Marrow-Derived Proangiogenic Cells Mediate Pulmonary Arteriole Stiffening via Serotonin 2B Receptor Dependent Mechanism. Nathaniel C Bloodworth, Cynthia R Clark, James D West, J Caleb Snider, Christa Gaskill, Sheila Shay, Christine Scott, Julie Bastarache, Santhi Gladson, Christy Moore, Reid D’Amico, Evan L Brittain, Harikrishna Tanjore, Timothy S Blackwell, Susan M Majka, W David Merryman. Circulation Research. 2018. https://doi.org/10.1161/CIRCRESAHA.118.313397
Targeting Cadherin-11 Prevents Notch1-Mediated Calcific Aortic Valve Disease. Clark CR, Bowler MA, Snider JC, Merryman WD. https://doi.org/10.1161/circulationaha.117.027771
The CNP/NPR-B/cGMP Axis is a Therapeutic Target in Calcific Aortic Stenosis. David WJ Armstrong, Deepak K Gupta, Brian R Lindman, W David Merryman. Journal of the American College of Cardiology: Basic to Translational Science. 2021. https://doi.org/10.1016/j.jacbts.2021.09.009